This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sue F. Kao, MD; Craig M. Morgan, MD; Terry J. Bergstrom, MD
Ann Arbor, Mich

Arch Ophthalmol. 1987;105(9):1175-1176.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Cyclocryotherapy, which decreases intraocular pressure by disrupting the function of the ciliary processes with a resultant decrease in aqueous humor production, is used to treat refractory glaucoma.^1-3 A number of well-known complications may occur following this procedure.^1,2 We observed a patient who developed massive subretinal fibrosis following cyclocryotherapy.

Report of a Case.

—A 62-year-old man with chronic open angle glaucoma in both eyes had uncontrolled intraocular pressure in the right eye despite maximum medical therapy and three unsuccessful filtration procedures; cyclocryotherapy was therefore performed on this eye. The intraocular pressure decreased from 37 to 6 mm Hg, and large choroidal effusions were noted. The choroidal effusions slowly diminished with a regimen of 1% atropine sulfate given twice daily and frequent use of topical prednisolone acetate.

The patient was unavailable for follow-up evaluation between the sixth and 12th weeks postoperatively. During this time, his visual acuity . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?